Cite
HARVARD Citation
Reich, K. et al. (2017). Comparison of ixekizumab with ustekinumab in moderate‐to‐severe psoriasis: 24‐week results from IXORA‐S, a phase III study. British journal of dermatology. pp. 1014-1023. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reich, K. et al. (2017). Comparison of ixekizumab with ustekinumab in moderate‐to‐severe psoriasis: 24‐week results from IXORA‐S, a phase III study. British journal of dermatology. pp. 1014-1023. [Online].